JULIO EDUARDO
NUÑEZ VILLOTA

2024

1. Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI

   Journal of the American College of Cardiology, Vol. 83, Núm. 9, pp. 904-914

2. Baseline resting heart rate and responsiveness to a home-based inspiratory muscle training program in long COVID

   Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 344-347

3. C-reactive protein in patients with acute heart failure and preserved ejection fraction

   Revista Espanola de Cardiologia, Vol. 77, Núm. 5, pp. 430-433

4. Carbohydrate antigen 125-guided pre-TAVI medical optimization: impact on quality of life and clinical outcomes

   Revista Espanola de Cardiologia

5. Circulating levels of carbohydrate antigen 125 in chronic heart failure: Useful or futile?

   European Journal of Heart Failure

6. Combinational Diuretics in Heart Failure

   Current Heart Failure Reports

7. Consensus document on the management of hyperkalemia

   Nefrologia

8. Consensus on the Approach to Hydrosaline Overload in Acute Heart Failure. SEMI/SEC/S.E.N. Recommendations

   Revista Espanola de Cardiologia

9. Correction to: Diagnosis of heart failure with preserved ejection fraction: a systematic narrative review of the evidence (Heart Failure Reviews, (2023), 29, 1, (179-189), 10.1007/s10741-023-10360-z)

   Heart Failure Reviews

10. Design and baseline characteristics of SALT-HF trial: hypertonic saline therapy in ambulatory heart failure

    ESC Heart Failure

11. Diagnosis of heart failure with preserved ejection fraction: a systematic narrative review of the evidence

    Heart Failure Reviews, Vol. 29, Núm. 1, pp. 179-189

12. Dietary sodium and fluid intake in heart failure. A clinical consensus statement of the Heart Failure Association of the ESC

    European Journal of Heart Failure

13. Differential sex-related effect of left ventricular ejection fraction trajectory on the risk of mortality and heart failure readmission following hospitalization for acute heart failure: A longitudinal study

    European Journal of Heart Failure

14. Effect of SGLT2 inhibitors on anemia and their possible clinical implications

    Nefrologia , Vol. 44, Núm. 2, pp. 165-172

15. Effect of paced heart rate on quality of life and natriuretic peptides for stage B or C heart failure with preserved ejection fraction: A secondary analysis of the myPACE trial

    European Journal of Heart Failure, Vol. 26, Núm. 1, pp. 167-176

16. Exercise training response according to baseline ferrokinetics in heart failure with preserved ejection fraction: A substudy of the TRAINING-HF trial

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 15, Núm. 2, pp. 681-689

17. Heart failure with preserved ejection fraction: Do we identify phenotypes or individualise the assessment?

    Revista Espanola de Geriatria y Gerontologia, Vol. 59, Núm. 3

18. Histopathology of congestive nephropathy: a case description and literature review

    ESC Heart Failure

19. Impact of Epicardial Adipose Tissue on Infarct Size and Left Ventricular Systolic Function in Patients with Anterior ST-Segment Elevation Myocardial Infarction

    Diagnostics, Vol. 14, Núm. 4

20. Improvement in left atrial strain following ferric carboxymaltose in heart failure: an analysis of the Myocardial-IRON trial

    ESC Heart Failure, Vol. 11, Núm. 2, pp. 1258-1262